Wall Street analysts predict that Owens & Minor, Inc. (NYSE:OMI) will report sales of $2.49 billion for the current quarter, according to Zacks. Two analysts have made estimates for Owens & Minor’s earnings. The lowest sales estimate is $2.47 billion and the highest is $2.52 billion. Owens & Minor reported sales of $2.54 billion during the same quarter last year, which indicates a negative year-over-year growth rate of 2%. The firm is expected to report its next quarterly earnings results on Tuesday, February 18th.
According to Zacks, analysts expect that Owens & Minor will report full-year sales of $9.84 billion for the current fiscal year, with estimates ranging from $9.81 billion to $9.86 billion. For the next year, analysts forecast that the firm will post sales of $9.83 billion, with estimates ranging from $9.76 billion to $9.91 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow Owens & Minor.
Owens & Minor (NYSE:OMI) last posted its earnings results on Wednesday, November 6th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.01. The company had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.45 billion. Owens & Minor had a positive return on equity of 4.89% and a negative net margin of 2.88%. Owens & Minor’s revenue was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.32 earnings per share.
Several institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. lifted its holdings in shares of Owens & Minor by 1.7% during the 2nd quarter. BlackRock Inc. now owns 9,353,164 shares of the company’s stock valued at $29,931,000 after purchasing an additional 153,546 shares during the last quarter. Blackstone Group Inc acquired a new position in shares of Owens & Minor in the 2nd quarter valued at $8,287,000. Invesco Ltd. increased its position in shares of Owens & Minor by 147.3% in the 2nd quarter. Invesco Ltd. now owns 2,404,873 shares of the company’s stock valued at $7,695,000 after acquiring an additional 1,432,480 shares during the period. State Street Corp increased its position in shares of Owens & Minor by 2.9% in the 3rd quarter. State Street Corp now owns 2,248,255 shares of the company’s stock valued at $13,062,000 after acquiring an additional 64,087 shares during the period. Finally, Morgan Stanley increased its position in shares of Owens & Minor by 21.9% in the 2nd quarter. Morgan Stanley now owns 1,803,457 shares of the company’s stock valued at $5,771,000 after acquiring an additional 324,480 shares during the period. Hedge funds and other institutional investors own 88.15% of the company’s stock.
Owens & Minor stock traded up $0.47 during mid-day trading on Monday, reaching $7.54. 1,768,198 shares of the company were exchanged, compared to its average volume of 1,564,962. The business has a fifty day moving average of $6.81 and a 200 day moving average of $4.88. The company has a debt-to-equity ratio of 3.57, a quick ratio of 0.85 and a current ratio of 1.74. The firm has a market cap of $473.90 million, a P/E ratio of 6.56 and a beta of 1.43. Owens & Minor has a 12-month low of $2.43 and a 12-month high of $8.43.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.
Further Reading: What are trading strategies for the 52-week high/low?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.